ESC 365 - Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions

ACNAP Premium Access

Optimization of antiplatelet therapy in patients with coronary artery disease and type 2 diabetes mellitus after percutaneous coronary interventions

Session: Coronary heart disease pathway

Topic: Pharmacotherapy

Speaker: Doctor M. Mukhamedova (Tashkent, UZ)

Event: ACNAP Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Muyassar Mukhamedova

CENTER FOR THE DEVELOPMENT OF PROFESSIONAL QUALIFICATION OF MEDICAL WORKERS, Tashkent (Uzbekistan)

0 follower

5 more presentations in this session

11-years of a nurse-led follow-up service for patients who have undergone percutaneous coronary intervention

Speaker: Miss S. Harrison (London, GB)

Suboptimal self-care trajectories of patients with coronary heart disease call for multiple levels of interventions: results from a longitudinal survey study

Speaker: Associate Professor B. Ingadottir (Reykjavik, IS)

Factors affecting the occurrence of postoperative atrial fibrillation in cardiac surgery patients.

Speaker: Doctor K. Lomper (Wroclaw, PL)

Infective endocarditis in octogenarians: a retrospective study in a single, high-volume surgical centre

Speaker: Mr M. Tamburini (Florence, IT)

Suture mediated closure after TAVI following haemostasis with the perclose vascular closure device a clinical nurse specialist experience

Speaker: Ms V. Perovic (Belgrade, RS)

Access the full session

Coronary heart disease pathway

Speakers: Doctor M. Mukhamedova, Miss S. Harrison, Associate Professor B. Ingadottir, Doctor K. Lomper, Mr M. Tamburini...

About the event

ACNAP Congress 2023

23 June - 24 June 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources